Uncleaved TFIIA is a substrate for taspase 1 and active in transcription

NCMLS, Department of Molecular Biology, 191, Radboud University of Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands.
Molecular and Cellular Biology (Impact Factor: 5.04). 05/2006; 26(7):2728-35. DOI: 10.1128/MCB.26.7.2728-2735.2006
Source: PubMed

ABSTRACT In higher eukaryotes, the large subunit of the general transcription factor TFIIA is encoded by the single TFIIAalphabeta gene and posttranslationally cleaved into alpha and beta subunits. The molecular mechanisms and biological significance of this proteolytic process have remained obscure. Here, we show that TFIIA is a substrate of taspase 1 as reported for the trithorax group mixed-lineage leukemia protein. We demonstrate that recombinant taspase 1 cleaves TFIIA in vitro. Transfected taspase 1 enhances cleavage of TFIIA, and RNA interference knockdown of endogenous taspase 1 diminishes cleavage of TFIIA in vivo. In taspase 1-/- MEF cells, only uncleaved TFIIA is detected. In Xenopus laevis embryos, knockdown of TFIIA results in phenotype and expression defects. Both defects can be rescued by expression of an uncleavable TFIIA mutant. Our study shows that uncleaved TFIIA is transcriptionally active and that cleavage of TFIIA does not serve to render TFIIA competent for transcription. We propose that cleavage fine tunes the transcription regulation of a subset of genes during differentiation and development.

Download full-text


Available from: Dimitra J Mitsiou, Jul 07, 2015
  • Source
    • "Our study suggests that Taspase1-mediated proteolytic cleavage of TFIIAa-b could serve to interconnect and fine-tune the general and tissuespecific transcription. In somatic cells, precursor TFIIAa-b binds TBP and is functionally active in transcription (Zhou et al., 2006). Therefore, in this context the cleavage of TFIIAa-b may serve to fine-tune the rate of transcription through regulating its stability, as processed TFIIAa/b is known to be more susceptible to degradation (Høiby et al., 2004). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The evolution of tissue-specific general transcription factors (GTFs), such as testis-specific TBP-related factor 2 (TRF2), enables the spatiotemporal expression of highly specialized genetic programs. Taspase1 is a protease that cleaves nuclear factors MLL1, MLL2, TFIIAα-β, and ALFα-β (TFIIAτ). Here, we demonstrate that Taspase1-mediated processing of TFIIAα-β drives mammalian spermatogenesis. Both Taspase1(-/-) and noncleavable TFIIAα-βnc/nc testes release immature germ cells with impaired transcription of Transition proteins (Tnp) and Protamines (Prm), exhibiting chromatin compaction defects and recapitulating those observed with TRF2(-/-) testes. Although the unprocessed TFIIA still complexes with TRF2, this complex is impaired in targeting and thus activating Tnp1 and Prm1 promoters. The current study presents a paradigm in which a protease (Taspase1) cleaves a ubiquitously expressed GTF (TFIIA) to enable tissue-specific (testis) transcription, meeting the demand for sophisticated regulation of distinct subsets of genes in higher organisms.
    Developmental Cell 10/2013; 27(2):188-200. DOI:10.1016/j.devcel.2013.09.025 · 10.37 Impact Factor
  • Source
    • "Taspase 1 was first identified as the enzyme responsible for the cleavage of the mixed lineage leukemia (MLL) protein, a proteolytic event which is crucial for MLL stabilization and, in consequence, for proper HOX gene expression and MLL-mediated tumorigenesis (Hsieh et al., 2003; Takeda et al., 2006). Taspase 1 is also over-expressed in solid tumors and acts on other regulatory proteins such as transcription factor IIA (TFIIA) or DNA polymerase zeta (DPOLZ), among other substrates (Zhou et al., 2006; Knauer et al., 2011). Interestingly, taspase 1 has been reported to be required for in vitro transformation of mouse embryonic fibroblasts by diverse combinations of oncogene pairs (Takeda et al., 2006), but also to maintain the transformed phenotype of these cells (Chen et al., 2010). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The "oncogene addiction" concept refers to the dependence of cancer cells on the function of the oncogenes responsible for their transformed phenotype, while the term "non-oncogene addiction" has been introduced to define the exacerbated necessity of the normal function of non-mutated genes. In this Perspective, we focus on the importance of proteolytic enzymes to maintain the viability of cancer cells and hypothesize that most, if not all, tumors present "addiction" to a number of proteolytic activities, which in turn may represent valuable targets of anti-cancer therapies, even without being mutated or over-expressed by the malignant cells.
    Frontiers in Oncology 09/2011; 1:25. DOI:10.3389/fonc.2011.00025
  • Source
    • "Our initial studies on the site-specific proteolysis of MLL indicated that proteolytic cleavage of MLL is not only required for its full activation but also regulates its stability (Hsieh et al. 2003a,b; Takeda et al. 2006). Interestingly , Taspase1-mediated site-specific proteolysis also controls the protein levels of another recently identified Taspase1 substrate, TFIIA (transcription factor II A) (Hoiby et al. 2004; Zhou et al. 2006). As our prior studies implicated that MLL N terminus is unstable, we envisioned that fusion partners must stabilize the common MLL N terminus for downstream gene regulation (Hsieh et al. 2003b). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Human chromosome 11q23 translocations disrupting MLL result in poor prognostic leukemias. It fuses the common MLL N-terminal approximately 1400 amino acids in-frame with >60 different partners without shared characteristics. In addition to the well-characterized activity of MLL in maintaining Hox gene expression, our recent studies established an MLL-E2F axis in orchestrating core cell cycle gene expression including Cyclins. Here, we demonstrate a biphasic expression of MLL conferred by defined windows of degradation mediated by specialized cell cycle E3 ligases. Specifically, SCF(Skp2) and APC(Cdc20) mark MLL for degradation at S phase and late M phase, respectively. Abolished peak expression of MLL incurs corresponding defects in G1/S transition and M-phase progression. Conversely, overexpression of MLL blocks S-phase progression. Remarkably, MLL degradation initiates at its N-terminal approximately 1400 amino acids, and tested prevalent MLL fusions are resistant to degradation. Thus, impaired degradation of MLL fusions likely constitutes the universal mechanism underlying all MLL leukemias. Our data conclude an essential post-translational regulation of MLL by the cell cycle ubiquitin/proteasome system (UPS) assures the temporal necessity of MLL in coordinating cell cycle progression.
    Genes & Development 11/2007; 21(19):2385-98. DOI:10.1101/gad.1574507 · 12.64 Impact Factor